Synergistic induccion of apoptosis in human breast cancer cells by proteasome and histone deacetylase inhibitors

被引：0
|
作者：
Domingo-Domenech, Josep
Tapia, Marian
Gascon, Pere
Albanell, Joan
Bachs, Oriol
Bosch, Marta
机构：
[1] Hosp Clin Barcelona, Oncol Dept, Barcelona, Spain
[2] Univ Barcelona, Fac Med, Barcelona, Spain
[3] Hosp del Mar, Oncol Dept, Barcelona, Spain
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4694
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors
    Kortenhorst, Madeleine S. Q.
    Wissing, Michel D.
    Rodriguez, Ronald
    Kachhap, Sushant K.
    Jans, Judith J. M.
    Van der Groep, Petra
    Verheul, Henk M. W.
    Gupta, Anuj
    Aiyetan, Paul O.
    van der Wall, Elsken
    Carducci, Michael A.
    Van Diest, Paul J.
    Marchionni, Luigi
    EPIGENETICS, 2013, 8 (09) : 907 - 920
  • [42] Histone deacetylase inhibitors sensitize cancer stem cells to PARP inhibitors in triple-negative breast cancer
    Liu, Yajing
    Martin-Trevino, Rachel
    Shang, Li
    Davis, April
    Wicha, Max
    Liu, Suling
    Burness, Monika
    CANCER RESEARCH, 2015, 75
  • [43] Treatment with Histone Deacetylase Inhibitors Creates 'BRCAness' and Sensitizes Human Triple Negative Breast Cancer Cells to PARP Inhibitors and Cisplatin
    Bhalla, K. N.
    Rao, R.
    Sharma, P.
    Das Gupta, S.
    Chauhan, L.
    Stecklein, S.
    Fiskus, W.
    CANCER RESEARCH, 2012, 72
  • [44] Interaction between histone demethylase and deacetylase may mediate activity of HDAC inhibitors in human breast cancer cells
    Huang, Yi
    Vasilatos, Shauna N.
    Boric, Lamia
    Shaw, Patrick G.
    Davidson, Nancy E.
    CANCER RESEARCH, 2011, 71
  • [45] Histone deacetylase inhibitors for the treatment of cancer stem cells
    Dvorakova, M.
    Vanek, T.
    MEDCHEMCOMM, 2016, 7 (12) : 2217 - 2231
  • [46] Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
    Wawruszak, Anna
    Kalafut, Joanna
    Okon, Estera
    Czapinski, Jakub
    Halasa, Marta
    Przybyszewska, Alicja
    Miziak, Paulina
    Okla, Karolina
    Rivero-Muller, Adolfo
    Stepulak, Andrzej
    CANCERS, 2019, 11 (02):
  • [47] Histone deacetylase inhibitors enhance retinoid response in human breast cancer cell lines
    Emionite, L
    Galmozzi, F
    Grattarola, M
    Boccardo, F
    Vergani, L
    Toma, S
    ANTICANCER RESEARCH, 2004, 24 (06) : 4019 - 4024
  • [48] Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells
    Schmidt, K
    Gust, R
    Jung, M
    ARCHIV DER PHARMAZIE, 1999, 332 (10) : 353 - 357
  • [49] Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells
    Zhou, Weiqiang
    Feng, Xiuyan
    Han, Han
    Guo, Shanchun
    Wang, Guangdi
    SCIENTIFIC REPORTS, 2016, 6
  • [50] Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells
    Weiqiang Zhou
    Xiuyan Feng
    Shanchun Han Han
    Guangdi Guo
    Scientific Reports, 6
12345